Giuseppina Lamantia
About
In The Last Decade
Giuseppina Lamantia
17 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Cardiology and Cardiovascular Medicine 4.4k
- Oncology 2.1k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Pulmonary and Respiratory Medicine 869
- Pathology and Forensic Medicine 359
Countries citing papers authored by Giuseppina Lamantia
This map shows the geographic impact of Giuseppina Lamantia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Lamantia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Lamantia more than expected).
Fields of papers citing papers by Giuseppina Lamantia
This network shows the impact of papers produced by Giuseppina Lamantia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Lamantia. The network helps show where Giuseppina Lamantia may publish in the future.
Co-authorship network of co-authors of Giuseppina Lamantia
This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Lamantia. A scholar is included among the top collaborators of Giuseppina Lamantia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Lamantia. Giuseppina Lamantia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 43 | |
| 3 | Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy breakdown → | 1124 |
| 4 | 1 | |
| 5 | Anthracycline-Induced Cardiomyopathy breakdown → | 772 |
| 6 | 444 | |
| 7 | 80 | |
| 8 | Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition breakdown → | 706 |
| 9 | 59 | |
| 10 | Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy | 13 |
| 11 | 45 | |
| 12 | Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy breakdown → | 659 |
| 13 | 223 | |
| 14 | 407 | |
| 15 | 25 | |
| 16 | 31 | |
| 17 | 75 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.